Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
DEMECAN logo — The German Medical Cannabis Expert

DEMECAN

The German Medical Cannabis Expert

Founded 2017 Germany Ebersbach, Germany 81 employees Unknown Total: $14.50M

General Information

Company Name DEMECAN
Founded Year 2017
Location Germany Ebersbach, Germany +1
Founders / Decision Makers
Team member Team member
Employees 81
Funding Stage Unknown
Social

Get notified when DEMECAN moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About DEMECAN

DEMECAN, "The German Medical Cannabis Expert," is the leading provider of medicinal cannabis in Germany. The company, founded in 2017, specializes in sustainable cultivation and wholesale distribution of medicinal cannabis, focusing on quality, innovation, and service. As pioneers in the industry, DEMECAN has established itself as the premier provider of medicinal cannabis in Germany, with a commitment to enhancing the quality of life for patients and increasing access to safe and effective cannabis products. In August 2024, the company received a Venture Round investment from Trog Hawley Capital. With its strong presence in the Health Care and Pharmaceutical industries, DEMECAN continues to shape the medical cannabis landscape in Germany from its headquarters. More information about the company can be found at Impressum.

Taxonomy: medicinal cannabis cultivation, wholesale distribution, sustainable cannabis products, medical cannabis industry solutions, patient access to cannabis therapies

Services & Products

medicinal cannabis production
pharmaceutical distribution
patient identification system

Target Customers

patients healthcare professionals pharmacies cannabis retail industry

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC •••••• 4
Investor
•••• •••• 		01 Oct 2024
Debt Financing •••••• 4
Investor Investor Investor
•••• •••• 		01 Dec 2022
Debt Financing •••••• 1
Investor
01 Mar 2021
Series A •••••• 1
Investor
01 Oct 2019

DEMECAN Alternatives & Competitors

View All Alternatives
DEMECAN vs
Sanity Group
Sanity Group Germany

Unlocking the potential of cannabinoids to develop innovative pharmaceuticals and consumer health pr...

Convertible Note
113 employees
Biotechnology, Health Care
Compare DEMECAN vs Sanity Group
DEMECAN vs
Botanical Holdings
Botanical Holdings

Botanical Holdings invests in all aspects of legal medicinal cannabis and has a growing portfolio wo...

Grant
Compare DEMECAN vs Botanical Holdings
DEMECAN vs
TTS Pharma Ltd
TTS Pharma Ltd United Kingdom

TTS Pharma | Advancing Innovation in Medicinal Cannabis & Wellness Solutions 🌿💡

Series B
2 employees
Biopharma, Biotechnology
Compare DEMECAN vs TTS Pharma Ltd
View all alternatives

FAQ About DEMECAN

The German Medical Cannabis Expert
DEMECAN was founded in 2017.
DEMECAN is headquartered in Ebersbach, Germany.
DEMECAN has approximately 81 employees.
DEMECAN has completed 4 funding rounds, raising a total of $14.50M. The latest funding stage is Unknown.
DEMECAN offers: medicinal cannabis production, pharmaceutical distribution, patient identification system.
Top alternatives and competitors to DEMECAN include Sanity Group, Botanical Holdings, TTS Pharma Ltd, BBS Pharmaceuticals, Linneo Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DEMECAN and Sanity Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors DEMECAN and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy